1. Academic Validation
  2. Using BODIPY FL-Sphingolipid Analogs to Study Sphingolipid Metabolism in Mouse Embryonic Stem Cells

Using BODIPY FL-Sphingolipid Analogs to Study Sphingolipid Metabolism in Mouse Embryonic Stem Cells

  • Bio Protoc. 2022 Nov 20;12(22):e4555. doi: 10.21769/BioProtoc.4555.
Wei Fan 1 Xiaoling Li 1
Affiliations

Affiliation

  • 1 Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Triangle Park, North Carolina, United States.
Abstract

Sphingolipids are important structural components of cellular membranes. They also function as prominent signaling molecules to control a variety of cellular events, such as cell growth, differentiation, and Apoptosis. Impaired sphingolipid metabolism, particularly defects in sphingolipid degradation, has been associated with many human diseases. Fluorescence sphingolipid analogs have been widely used as efficient probes to study sphingolipid metabolism and intracellular trafficking in living mammalian cells. Compared with nitrobenzoxadiazole fluorophores (NBD FL), the boron dipyrromethene difluoride fluorophores (BODIPY FL) have much higher absorptivity and fluorescence quantum. These features allow more intensive labeling of cells for fluorescence microscopy imaging and flow cytometry analysis. Here, we describe a protocol employing BODIPY FL-labeled sphingolipid analogs to elucidate sphingolipid internalization, trafficking, and endocytosis in mouse embryonic stem cells. This protocol was validated in: eLife (2022), DOI: 10.7554/eLife.67452 Graphical abstract.

Keywords

BODIPY; Golgi complex; Internalization; Metabolism; Plasma membrane; Sphingolipid; Sphingomyelin.

Figures
Products